ArticleBMC cancer2014

A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients.

Susanne Blank et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.